TNSN08347A1 - Dibenzylamines et derives - Google Patents
Dibenzylamines et derivesInfo
- Publication number
- TNSN08347A1 TNSN08347A1 TNP2008000347A TNSN08347A TNSN08347A1 TN SN08347 A1 TNSN08347 A1 TN SN08347A1 TN P2008000347 A TNP2008000347 A TN P2008000347A TN SN08347 A TNSN08347 A TN SN08347A TN SN08347 A1 TNSN08347 A1 TN SN08347A1
- Authority
- TN
- Tunisia
- Prior art keywords
- des
- cholestérol
- taux
- les
- certains
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C261/00—Derivatives of cyanic acid
- C07C261/04—Cyanamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/16—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
- C07C275/20—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
- C07C275/24—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
- C07D257/06—Five-membered rings with nitrogen atoms directly attached to the ring carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Abstract
Des dibenzylamines et dérivés de dibenzylamines des compositions pharmaceutiques contenant ces composés et l'utilisation de ces composés pour élever les taux plasmatiques de certains lipides, comprenant le cholestérol-liprotéines haute densité, et pour abaisser les taux plasmatiques de certains autres lipides, tels que le cholestérol-LDL et les triglycérides et, en conséquence, pour traiter des maladies qui sont exacerbées par des taux bas de cholestérol-HDL et/ou des taux élevés de cholestérol-LDL et de triglycérides, telles que l'athérosclérose et des maladies cardiovasculaires chez certains mammifères, y compris les êtres humains.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US78099306P | 2006-03-10 | 2006-03-10 | |
US11/619,277 US7919506B2 (en) | 2006-03-10 | 2007-01-03 | Dibenzyl amine compounds and derivatives |
PCT/IB2007/000527 WO2007105050A1 (fr) | 2006-03-10 | 2007-02-26 | Dibenzylamines et leurs dérivés |
Publications (1)
Publication Number | Publication Date |
---|---|
TNSN08347A1 true TNSN08347A1 (fr) | 2009-12-29 |
Family
ID=38088523
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TNP2008000347A TNSN08347A1 (fr) | 2006-03-10 | 2008-09-09 | Dibenzylamines et derives |
Country Status (26)
Country | Link |
---|---|
US (1) | US7919506B2 (fr) |
EP (1) | EP1996564A1 (fr) |
JP (1) | JP5075843B2 (fr) |
KR (1) | KR101058312B1 (fr) |
AP (1) | AP2008004604A0 (fr) |
AR (1) | AR059803A1 (fr) |
AU (1) | AU2007226261B2 (fr) |
BR (1) | BRPI0709003A2 (fr) |
CA (2) | CA2645294C (fr) |
CR (1) | CR10264A (fr) |
DO (1) | DOP2007000047A (fr) |
EA (1) | EA200801815A1 (fr) |
EC (1) | ECSP088729A (fr) |
GT (1) | GT200700020A (fr) |
IL (1) | IL193571A (fr) |
MA (1) | MA30271B1 (fr) |
MX (1) | MX2008010863A (fr) |
NL (1) | NL2000514C2 (fr) |
NO (1) | NO20083641L (fr) |
PE (1) | PE20080118A1 (fr) |
RS (1) | RS20080410A (fr) |
SG (1) | SG176418A1 (fr) |
TN (1) | TNSN08347A1 (fr) |
TW (1) | TW200738652A (fr) |
UY (1) | UY30196A1 (fr) |
WO (1) | WO2007105050A1 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8383660B2 (en) * | 2006-03-10 | 2013-02-26 | Pfizer Inc. | Dibenzyl amine compounds and derivatives |
BR112013004882A2 (pt) | 2010-08-31 | 2016-05-03 | Snu R&Db Foundation | utilização de reprogramação fetal de agonista ppar delta |
CN103351354B (zh) * | 2013-06-09 | 2015-08-12 | 西安近代化学研究所 | 1-甲基-5-氨基四唑合成方法 |
CN103524445A (zh) * | 2013-09-09 | 2014-01-22 | 南通市华峰化工有限责任公司 | 一种1-甲基-5氨基四氮唑的合成生产方法 |
TW201609661A (zh) * | 2013-12-05 | 2016-03-16 | 拜耳作物科學公司 | N-環烷基-n-{[2-(1-經取代環烷基)苯基]亞甲基}-(硫代)甲醯胺衍生物 |
Family Cites Families (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3562A (en) | 1844-04-25 | Improvement in seed-planters | ||
US30577A (en) | 1860-11-06 | Truss-bridge | ||
US2161938A (en) | 1934-07-31 | 1939-06-13 | Soc Of Chemical Ind | Imidazolines |
DE905738C (de) | 1943-06-11 | 1954-11-02 | Diwag Chemische Fabriken Ag | Verfahren zur Herstellung basischer Thymoldimethylaminoaethylaether |
FR1165845A (fr) | 1955-05-28 | 1958-10-29 | Philips Nv | Amines secondaires portant des substituants et leur préparation |
CH366523A (de) | 1958-04-14 | 1963-01-15 | Eprova Ag | Verfahren zur Herstellung der neuen 1,3,4,6- und 1,3,4,5-Tetranicotinoyl-fructose |
NL108640C (fr) | 1958-05-07 | |||
US2970082A (en) | 1958-10-07 | 1961-01-31 | Walker Lab Inc | Aluminum nicotinate compositions for hypercholesteremia |
DE1102973B (de) | 1960-03-25 | 1961-03-23 | Bayer Ag | Verfahren zur Herstellung von hoch gereinigten Kallikrein-Praeparaten |
DE1170417B (de) | 1960-11-08 | 1964-05-21 | Recip Ab | Verfahren zur Herstellung eines Diphenyl-butylamins mit die Coronargefaesse erweiternder Wirkung |
DE1154810B (de) | 1961-04-01 | 1963-09-26 | Knoll Ag | Verfahren zur Herstellung basisch substituierter Phenylacetonitrile |
DE1518133B1 (de) | 1961-10-05 | 1970-08-20 | Farmaceutici Italia | Verfahren zur Herstellung eines neuen hypotensiv wirkenden Hendekapeptids |
US3262977A (en) | 1962-03-10 | 1966-07-26 | Chinoin Gyogyszer Es Vegyeszet | N-aralkyl-1, 1-diphenyl-propylamine derivatives |
US3228943A (en) | 1962-06-11 | 1966-01-11 | Lumilysergol derivatives | |
US3338899A (en) | 1962-07-09 | 1967-08-29 | Aron Samuel | 3-phenyl-5-amino-1, 2, 4-oxadiazole compounds |
US3238215A (en) | 1963-10-17 | 1966-03-01 | Sterling Drug Inc | 1-[(3-, 2-, and 1-indolyl)-lower-alkyl-, lower-alkenyl-, and lower-alkynyl]piperidines |
NL127065C (fr) | 1964-04-22 | |||
NL6514807A (fr) | 1964-11-18 | 1966-05-20 | ||
FR1460571A (fr) | 1965-06-10 | 1966-03-04 | Innothera Lab Sa | Composés thiényl acétiques et leur préparation |
FR6087M (fr) | 1967-01-10 | 1968-06-04 | ||
DE1670827C3 (de) | 1967-03-20 | 1974-10-24 | Bayer Ag, 5090 Leverkusen | 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridin |
US3511836A (en) | 1967-12-13 | 1970-05-12 | Pfizer & Co C | 2,4,6,7-tetra substituted quinazolines |
BE729170A (fr) | 1968-03-02 | 1969-08-01 | ||
GB1218591A (en) | 1968-04-03 | 1971-01-06 | Delalande Sa | Derivatives of n-(3,4,5-trimethoxy cennamoyl) piperazine and their process of preparation |
FR2092133B1 (fr) | 1970-05-06 | 1974-03-22 | Orsymonde | |
US3669968A (en) | 1970-05-21 | 1972-06-13 | Pfizer | Trialkoxy quinazolines |
BE795735A (fr) | 1972-03-06 | 1973-06-18 | Cerm Cent Europ Rech Mauvernay | Nouvelles ethylenediamines substituees a activite cardiovasculaire |
GB1435139A (en) | 1972-08-17 | 1976-05-12 | Sumitomo Chemical Co | Thiazole derivatives |
US3985758A (en) | 1973-02-20 | 1976-10-12 | Yamanouchi Pharmaceutical Co., Ltd. | 1,4-Dihydropyridine derivatives |
US4146643A (en) | 1973-12-18 | 1979-03-27 | Sandoz Ltd. | Increasing vigilance or treating cerebral insufficiency with substituted vincamines |
NL175059C (nl) | 1974-02-23 | Boehringer Mannheim Gmbh | Bereiding van bloeddrukverlagende stoffen en van preparaten die ze bevatten. | |
US4338322A (en) | 1975-07-02 | 1982-07-06 | Fujisawa Pharmaceutical Co., Ltd. | 1,4-Dihydropyridine derivatives, pharmaceutical compositions containing same and methods of effecting vasodilation using same |
US4466972A (en) | 1977-06-20 | 1984-08-21 | Sandoz Ltd. | Benzoxadiazoles and benzothiadiazoles, their preparation and pharmaceutical compositions containing them |
DE2733747C2 (de) | 1977-07-27 | 1979-09-27 | Hoechst Ag, 6000 Frankfurt | Verfahren zur Herstellung von 2,2 Dichlorhydrazobenzol |
US4188390A (en) | 1977-11-05 | 1980-02-12 | Pfizer Inc. | Antihypertensive 4-amino-2-[4-(1,4-benzodioxan-2-carbonyl) piperazin-1-yl or homopiperazin-1-yl]quinazolines |
JPS55301A (en) | 1978-02-14 | 1980-01-05 | Yamanouchi Pharmaceut Co Ltd | 1,4-dihydropyridine-3,5-dicarboxylic ester derivative and its preparation |
IT1094076B (it) | 1978-04-18 | 1985-07-26 | Acraf | Cicloalchiltriazoli |
SE429652B (sv) | 1978-06-30 | 1983-09-19 | Haessle Ab | 2.6-dimetyl-4-(2.3-diklorfenyl)-1.4-dihydropyridin-3.5-dikarboxylsyra-3-metylester-5-etylester |
DE2845770A1 (de) | 1978-10-19 | 1980-04-30 | Schering Ag | Neue prostacyclin-derivate und verfahren zu ihrer herstellung |
JPS56110665A (en) | 1980-02-08 | 1981-09-01 | Yamanouchi Pharmaceut Co Ltd | Sulfamoyl-substituted phenetylamine derivative and its preparation |
DK161312C (da) | 1982-03-11 | 1991-12-09 | Pfizer | Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden |
EP0094159B1 (fr) | 1982-05-10 | 1990-03-14 | Takeda Chemical Industries, Ltd. | Dérivés de la dihydropyridine, leur préparation et leur application |
DE3382204D1 (de) | 1982-10-15 | 1991-04-18 | Kyowa Hakko Kogyo Kk | 1,4-dihydropyridin-derivate. |
US4567175A (en) | 1983-06-03 | 1986-01-28 | Tanabe Seiyaku Co., Ltd. | 8-Chloro-1,5-benzothiazepine derivatives |
GB8403866D0 (en) | 1984-02-14 | 1984-03-21 | Recordati Chem Pharm | Diphenylalkylaminoalkyl esters |
US4672068A (en) | 1984-05-04 | 1987-06-09 | Fujirebio Kabushiki Kaisha | Antihypertensive 1,4-dihydropyridines having a conjugated ester |
NZ212895A (en) | 1984-08-22 | 1988-07-28 | Glaxo Spa | 1,4-dihydropyridine derivatives and pharmaceutical compositions |
WO1987000838A1 (fr) | 1985-07-29 | 1987-02-12 | Santen Pharmaceutical Co., Ltd. | Nouveaux derives de benzothiazine |
US4885284A (en) | 1986-01-22 | 1989-12-05 | Nissan Chemical Industries Ltd. | Dihydropyridine-5-phosphonic acid cyclic propylene ester |
CA1319144C (fr) | 1986-11-14 | 1993-06-15 | Quirico Branca | Derives tetrahydronaphtalene |
ATE61588T1 (de) | 1987-08-03 | 1991-03-15 | Delagrange Lab | 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. |
EP0832069B1 (fr) | 1995-06-07 | 2003-03-05 | Pfizer Inc. | DERIVES DE BIPHENYL-2-ACIDE CARBOXYLIQUE-TETRAHYDRO-ISOQUINOLEINE-6-YL AMIDES, PREPARATION DE CES AMIDES ET UTILISATION EN TANT QU'INHIBITEURS DE LA PROTEINE DE TRANSFERT DE TRIGLYCERIDE MICROSOMAL ET/OU DE LA SECRETION D'APOLIPOPROTEINES B (Apo B) |
SK65499A3 (en) | 1996-11-27 | 2001-05-10 | Pfizer | Apo b-secretion/mtp inhibitory amides |
JP2894445B2 (ja) | 1997-02-12 | 1999-05-24 | 日本たばこ産業株式会社 | Cetp活性阻害剤として有効な化合物 |
PA8471201A1 (es) | 1998-06-16 | 2000-09-29 | Pfizer Prod Inc | Combinaciones terapeuticas que comprenden un modulador del receptor de estrogenos selectivo y hormona paratiroidea |
JP2003221376A (ja) | 2001-11-21 | 2003-08-05 | Japan Tobacco Inc | Cetp活性阻害剤 |
KR100634195B1 (ko) | 2002-08-30 | 2006-10-16 | 니뽄 다바코 산교 가부시키가이샤 | 디벤질아민 화합물 및 그 의약 용도 |
JP3630676B2 (ja) * | 2002-08-30 | 2005-03-16 | 日本たばこ産業株式会社 | ジベンジルアミン化合物及びその医薬用途 |
US6653334B1 (en) * | 2002-12-27 | 2003-11-25 | Kowa Co., Ltd. | Benzoxazole compound and pharmaceutical composition containing the same |
CN1942428A (zh) | 2004-04-13 | 2007-04-04 | 默克公司 | Cetp抑制剂 |
DOP2005000123A (es) | 2004-07-02 | 2011-07-15 | Merck Sharp & Dohme | Inhibidores de cetp |
EP1817297A1 (fr) | 2004-11-23 | 2007-08-15 | Pfizer Products Inc. | Composes et derives de dibenzyl amine |
UY30117A1 (es) * | 2006-01-31 | 2007-06-29 | Tanabe Seiyaku Co | Compuesto amina trisustituido |
-
2007
- 2007-01-03 US US11/619,277 patent/US7919506B2/en not_active Expired - Fee Related
- 2007-02-26 EA EA200801815A patent/EA200801815A1/ru unknown
- 2007-02-26 AP AP2008004604A patent/AP2008004604A0/xx unknown
- 2007-02-26 SG SG2011077658A patent/SG176418A1/en unknown
- 2007-02-26 EP EP07705672A patent/EP1996564A1/fr not_active Withdrawn
- 2007-02-26 RS RSP-2008/0410A patent/RS20080410A/sr unknown
- 2007-02-26 WO PCT/IB2007/000527 patent/WO2007105050A1/fr active Application Filing
- 2007-02-26 JP JP2008558924A patent/JP5075843B2/ja not_active Expired - Fee Related
- 2007-02-26 CA CA2645294A patent/CA2645294C/fr not_active Expired - Fee Related
- 2007-02-26 KR KR1020087022006A patent/KR101058312B1/ko not_active IP Right Cessation
- 2007-02-26 CA CA2717249A patent/CA2717249A1/fr not_active Abandoned
- 2007-02-26 BR BRPI0709003-0A patent/BRPI0709003A2/pt not_active Application Discontinuation
- 2007-02-26 AU AU2007226261A patent/AU2007226261B2/en not_active Expired - Fee Related
- 2007-02-26 MX MX2008010863A patent/MX2008010863A/es active IP Right Grant
- 2007-03-01 NL NL2000514A patent/NL2000514C2/nl not_active IP Right Cessation
- 2007-03-08 GT GT200700020A patent/GT200700020A/es unknown
- 2007-03-08 PE PE2007000255A patent/PE20080118A1/es not_active Application Discontinuation
- 2007-03-08 UY UY30196A patent/UY30196A1/es not_active Application Discontinuation
- 2007-03-09 DO DO2007000047A patent/DOP2007000047A/es unknown
- 2007-03-09 AR ARP070100980A patent/AR059803A1/es unknown
- 2007-03-09 TW TW096108174A patent/TW200738652A/zh unknown
-
2008
- 2008-08-20 IL IL193571A patent/IL193571A/en not_active IP Right Cessation
- 2008-08-22 NO NO20083641A patent/NO20083641L/no not_active Application Discontinuation
- 2008-08-29 CR CR10264A patent/CR10264A/es not_active Application Discontinuation
- 2008-09-09 TN TNP2008000347A patent/TNSN08347A1/fr unknown
- 2008-09-10 MA MA31225A patent/MA30271B1/fr unknown
- 2008-09-10 EC EC2008008729A patent/ECSP088729A/es unknown
Also Published As
Publication number | Publication date |
---|---|
CA2645294A1 (fr) | 2007-09-20 |
GT200700020A (es) | 2007-11-15 |
AR059803A1 (es) | 2008-04-30 |
CR10264A (es) | 2008-09-23 |
US7919506B2 (en) | 2011-04-05 |
SG176418A1 (en) | 2011-12-29 |
NO20083641L (no) | 2008-09-29 |
EA200801815A1 (ru) | 2009-02-27 |
DOP2007000047A (es) | 2007-09-15 |
MX2008010863A (es) | 2008-09-03 |
CA2645294C (fr) | 2011-08-30 |
CA2717249A1 (fr) | 2007-09-20 |
JP2009531312A (ja) | 2009-09-03 |
AU2007226261A1 (en) | 2007-09-20 |
IL193571A (en) | 2012-12-31 |
UY30196A1 (es) | 2007-10-31 |
EP1996564A1 (fr) | 2008-12-03 |
US20070213371A1 (en) | 2007-09-13 |
JP5075843B2 (ja) | 2012-11-21 |
RS20080410A (en) | 2009-09-08 |
TW200738652A (en) | 2007-10-16 |
PE20080118A1 (es) | 2008-02-22 |
MA30271B1 (fr) | 2009-03-02 |
AP2008004604A0 (en) | 2008-10-31 |
KR101058312B1 (ko) | 2011-08-22 |
WO2007105050A1 (fr) | 2007-09-20 |
BRPI0709003A2 (pt) | 2011-06-21 |
AU2007226261B2 (en) | 2012-08-16 |
NL2000514C2 (nl) | 2009-03-31 |
KR20080091861A (ko) | 2008-10-14 |
ECSP088729A (es) | 2008-10-31 |
NL2000514A1 (nl) | 2007-09-11 |
IL193571A0 (en) | 2009-05-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TNSN07200A1 (fr) | Dibenzylamines et derives | |
MA30272B1 (fr) | Derives de dibenzylamines servant d'inhibiteurs de cetp. | |
TNSN06447A1 (fr) | Composes heteroaryle et phenylsulfamoyle substitues | |
TNSN07100A1 (fr) | Derives de 1, 2, 3, 4- tetrahydroquinoleine substitues en position 2 et a substituant 4-amino | |
MA31151B1 (fr) | Inhibiteurs de mapk/erk kinase | |
MA31906B1 (fr) | Inhibiteurs de la replication du virus de limmunodeficience humaine | |
TNSN07476A1 (fr) | Derives de n-(pyridine -2- yl) - sulfonamide | |
MA30717B1 (fr) | Derives de pyridin-3-yle en tant qu'agents immunomodulateurs | |
MA30718B1 (fr) | Derives de pyridin-4-yle en tant qu'agents immunomodulateurs. | |
TNSN08347A1 (fr) | Dibenzylamines et derives | |
RS51185B (sr) | Kompozicije za vaginalnu primenu | |
UA87856C2 (ru) | Алкильные производные как модуляторы метаботропных рецепторов глутамата | |
TNSN08099A1 (fr) | 1-h-imidazopyridines a substituant hydroxy et procedes | |
MA31764B1 (fr) | Composés et compositions en tant que modulateurs de l'activité de gpr119 | |
TN2011000454A1 (fr) | Derives de benzofurannyle utilises comme inhibiteurs de glucokinase | |
MA30557B1 (fr) | Composés de pyrrolopyrimidine et leurs utilisations. | |
MA29141B1 (fr) | Pyrrolopyrazoles, servant de puissants inhibiteurs de kinases | |
DE502006004808D1 (de) | O/w wachsdispersionen und hieraus erhältliche gipsprodukte | |
MA31433B1 (fr) | Inhibiteurs de la p70 s6 kinase | |
MA30291B1 (fr) | Derives de l'azolopyridin-3-one en tant qu'inhibiteurs de la lipase endotheliale | |
MA27728A1 (fr) | Antagonistes des recepteurs de cgrp | |
MA31874B1 (fr) | Inhibiteurs de bêta-lactamases | |
TNSN06368A1 (fr) | 3-(4-heteroarylcyclohexylamino) cyclopentanecarboxamides servant de modulateurs de recepteurs de chimiokines | |
MA30655B1 (fr) | Composes organiques. | |
EA200901653A1 (ru) | ОПОСРЕДУЕМОЕ PHKi ИНГИБИРОВАНИЕ ЭКСПРЕССИИ АЛЬФА-EnaC |